McDAY proud member of The Parenteral Drug Association (PDA)

McDAY proud member of The Parenteral Drug Association (PDA)

pda-logoAugust 10, 2016, Philadelphia, PA.  –  Susan Stipa, president of McDAY, announced that the company has become a member of PDA. The Parenteral Drug Association (PDA) is the leading global facilitator of science, technology, and regulatory information. The PDA creates awareness and understanding of important issues facing the pharmaceutical and biopharmaceutical community and delivers education for the community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and expertise to advance pharmaceutical / biopharmaceutical manufacturing science and regulation so members can better serve patients.


“We like to go to the places where our clients get their best technical information, and PDA supports that mission. Many of McDAY’s clients are involved in the manufacturing and technology side of the biopharmaceutical world, and PDA’s small, intimate and very specific conferences appeal to our sense of how information can and should be shared.”

Susan mentioned that the company will attend the Universe of Pre-Filled Syringe conference in Huntingdon Beach, CA in October.




PDA was founded in 1946 as the Parenteral Drug Association by a small group of pharmaceutical manufacturers who recognized the need for an organization to disseminate technical information within the industry. Today, coordinated through its headquarters and its Training & Research Institute in Bethesda, Maryland, PDA volunteers worldwide carry out its mission of promoting the exchange of rapidly evolving information on the latest technology and regulations concerning high-quality pharmaceutical production.


PDA is the recognized authoritative voice and leading technical organization in the field of parenteral science and technology. Through the development of Technical Reports and responses to regulatory initiatives, PDA, and its members influence the future course of pharmaceutical products technology.


With more than 10,000 individual members worldwide, PDA draws its strength from the technical expertise of its membership. Conferences, meetings, and courses bring together pharmaceutical manufacturers, suppliers, users, academics and regulatory officials to discuss issues of mutual interest. These exchanges of technical knowledge and expertise assist the advancement of pharmaceutical science and technology in the interest of public health.